Nonvascular drug-eluting stent coated with sodium caprate-incorporated polyurethane for the efficient penetration of paclitaxel into tumor tissue
- 24 September 2014
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 29 (8) , 1133-1144
Abstract
To increase the therapeutic potency of nonvascular drug-eluting stents, sodium caprate was employed as a drug-penetration enhancer. A polytetrafluoroethylene-covered drug-eluting stent was coated with a mixture containing sodium caprate, paclitaxel, and polyurethane via the rolling coating technique. The coated stent has a smooth membrane surface with a 40-µm membrane thickness. Paclitaxel was released from the coated stent for two months. In the multilayered cell sheet model, sodium caprate in the polyurethane membrane (PUSC10) showed the possibility of enhancing the paclitaxel tissue penetration. The amount of penetrated paclitaxel for the sodium caprate-containing polyurethane membrane (PUSC10) was two times higher than that of sodium caprate-free polyurethane membrane. Additionally, the potential of sodium caprate was confirmed by a tumor-bearing small animal model. PUSC10 incorporated with Nile red (as a model fluorescence dye for visualization of drug penetration; PUSC10–Nile red) or PUSC10 incorporated with paclitaxel (PUSC10–paclitaxel) membrane was implanted at tumor sites in Balb/c mice. In the case of PUSC10–Nile red, the tissue penetration depth of Nile red was significantly increased from 30 µm (without sodium caprate) to 1060 µm (with sodium caprate). After seven days, an almost four times higher therapeutic area of PUSC10–paclitaxel was observed compared to that of polyurethane–paclitaxel (without sodium caprate) by a terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The results indicate that sodium caprate improves the penetration and therapeutic efficiencies of drugs in drug-eluting stents, and thus, it has potential for local stent therapy.Keywords
This publication has 39 references indexed in Scilit:
- Penetration enhancersAdvanced Drug Delivery Reviews, 2012
- Safety evaluation of self‐expanding metallic biliary stents eluting gemcitabine in a porcine modelJournal of Gastroenterology and Hepatology, 2012
- An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosisBiomaterials, 2011
- Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagusAdvanced Drug Delivery Reviews, 2006
- The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membraneGastrointestinal Endoscopy, 2005
- Impact of transport and drug properties on the local pharmacology of drug-eluting stentsInternational Journal of Cardiovascular Interventions, 2003
- Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alterationJournal of Clinical Investigation, 2002
- Histological and bioadhesion studies on buccal bioadhesive tablets containing a penetration enhancer sodium glycodeoxycholateInternational Journal of Pharmaceutics, 1998
- Patency and reintervention rates during routine TIPSS surveillanceCardioVascular and Interventional Radiology, 1998
- Penetration of Ciprofloxacin into Bone: A New Bioabsorbable ImplantJournal of Investigative Surgery, 1995